MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies

NCT06543511 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Contractual issues. Will be re-submitted as new protocol.

Conditions

Myeloid Malignancy
Myeloid Malignancies
Blood Cancer
Blood Cancers

Interventions

OTHER: Genetic Blood Test

Sponsor

Dana-Farber Cancer Institute